202 related articles for article (PubMed ID: 9712787)
1. Deletion of repeats in the alpha C protein enhances the pathogenicity of group B streptococci in immune mice.
Gravekamp C; Rosner B; Madoff LC
Infect Immun; 1998 Sep; 66(9):4347-54. PubMed ID: 9712787
[TBL] [Abstract][Full Text] [Related]
2. Variation in repeat number within the alpha C protein of group B streptococci alters antigenicity and protective epitopes.
Gravekamp C; Horensky DS; Michel JL; Madoff LC
Infect Immun; 1996 Sep; 64(9):3576-83. PubMed ID: 8751902
[TBL] [Abstract][Full Text] [Related]
3. Group B streptococci escape host immunity by deletion of tandem repeat elements of the alpha C protein.
Madoff LC; Michel JL; Gong EW; Kling DE; Kasper DL
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4131-6. PubMed ID: 8633028
[TBL] [Abstract][Full Text] [Related]
4. Tandem repeat deletion in the alpha C protein of group B streptococcus is recA independent.
Puopolo KM; Hollingshead SK; Carey VJ; Madoff LC
Infect Immun; 2001 Aug; 69(8):5037-45. PubMed ID: 11447184
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and protective efficacy of the alpha C protein of group B streptococci are inversely related to the number of repeats.
Gravekamp C; Kasper DL; Michel JL; Kling DE; Carey V; Madoff LC
Infect Immun; 1997 Dec; 65(12):5216-21. PubMed ID: 9393818
[TBL] [Abstract][Full Text] [Related]
6. Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines.
Gravekamp C; Kasper DL; Paoletti LC; Madoff LC
Infect Immun; 1999 May; 67(5):2491-6. PubMed ID: 10225912
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of group B protective surface protein, a new cell surface protective antigen of group B streptococci.
Erdogan S; Fagan PK; Talay SR; Rohde M; Ferrieri P; Flores AE; Guzmán CA; Walker MJ; Chhatwal GS
Infect Immun; 2002 Feb; 70(2):803-11. PubMed ID: 11796614
[TBL] [Abstract][Full Text] [Related]
8. Immunization with a single-repeat alpha C protein may prevent escape of lower repeat mutants of group B Streptococcus.
Gravekamp C; Kasper DL; Madoff LC
Adv Exp Med Biol; 1997; 418():855-7. PubMed ID: 9331787
[No Abstract] [Full Text] [Related]
9. Upstream short sequence repeats regulate expression of the alpha C protein of group B Streptococcus.
Puopolo KM; Madoff LC
Mol Microbiol; 2003 Nov; 50(3):977-91. PubMed ID: 14617155
[TBL] [Abstract][Full Text] [Related]
10. Recombinant group B streptococcus Beta C protein and a variant with the deletion of its immunoglobulin A-binding site are protective mouse maternal vaccines and effective carriers in conjugate vaccines.
Yang HH; Madoff LC; Guttormsen HK; Liu YD; Paoletti LC
Infect Immun; 2007 Jul; 75(7):3455-61. PubMed ID: 17470542
[TBL] [Abstract][Full Text] [Related]
11. A protective surface protein from type V group B streptococci shares N-terminal sequence homology with the alpha C protein.
Lachenauer CS; Madoff LC
Infect Immun; 1996 Oct; 64(10):4255-60. PubMed ID: 8926097
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a novel leucine-rich repeat protein antigen from group B streptococci that elicits protective immunity.
Seepersaud R; Hanniffy SB; Mayne P; Sizer P; Le Page R; Wells JM
Infect Immun; 2005 Mar; 73(3):1671-83. PubMed ID: 15731068
[TBL] [Abstract][Full Text] [Related]
13. Characterization of two distinct opsonic and protective epitopes within the alpha C protein of the group B Streptococcus.
Kling DE; Gravekamp C; Madoff LC; Michel JL
Infect Immun; 1997 Apr; 65(4):1462-7. PubMed ID: 9119488
[TBL] [Abstract][Full Text] [Related]
14. Protection of neonatal mice from group B streptococcal infection by maternal immunization with beta C protein.
Madoff LC; Michel JL; Gong EW; Rodewald AK; Kasper DL
Infect Immun; 1992 Dec; 60(12):4989-94. PubMed ID: 1452329
[TBL] [Abstract][Full Text] [Related]
15. Temperature-Induced Self-Assembly of the Group B Streptococcus (GBS) Fusion Antigen GBS-NN.
Rose F; Roovers S; Fano M; Harloff-Helleberg S; Kirkensgaard JJK; Hejnaes K; Fischer P; Foged C
Mol Pharm; 2018 Jul; 15(7):2584-2593. PubMed ID: 29745668
[TBL] [Abstract][Full Text] [Related]
16. Immunological fingerprinting of group B streptococci: from circulating human antibodies to protective antigens.
Meinke AL; Senn BM; Visram Z; Henics TZ; Minh DB; Schüler W; Neubauer C; Gelbmann D; Noiges B; Sinzinger J; Hanner M; Dewasthaly S; Lundberg U; Hordnes K; Masoud H; Sevelda P; von Gabain A; Nagy E
Vaccine; 2010 Oct; 28(43):6997-7008. PubMed ID: 20732466
[TBL] [Abstract][Full Text] [Related]
17. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
Kasper DL; Paoletti LC; Wessels MR; Guttormsen HK; Carey VJ; Jennings HJ; Baker CJ
J Clin Invest; 1996 Nov; 98(10):2308-14. PubMed ID: 8941648
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of the alpha C protein antigen gene, bca, by a novel shuttle/suicide vector results in attenuation of virulence and immunity in group B Streptococcus.
Li J; Kasper DL; Ausubel FM; Rosner B; Michel JL
Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13251-6. PubMed ID: 9371832
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic diversity in the alpha C protein of group B streptococci.
Madoff LC; Hori S; Michel JL; Baker CJ; Kasper DL
Infect Immun; 1991 Aug; 59(8):2638-44. PubMed ID: 1855984
[TBL] [Abstract][Full Text] [Related]
20. Recombinant group B Streptococcus alpha-like protein 3 is an effective immunogen and carrier protein.
Yang HH; Mascuch SJ; Madoff LC; Paoletti LC
Clin Vaccine Immunol; 2008 Jul; 15(7):1035-41. PubMed ID: 18463225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]